EGFR and lung carcinoma: For example, a critical role for tankyrase and Wnt/β-catenin signaling was identified for maintenance of lung cancer cells during EGFR inhibition and subsequent inhibition of tankyrase significantly enhanced the antitumor activity of EGFR inhibitors in NSCLC cells [55].